Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A4 | P14672 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6254596 | 0.90 | SLC2A4 (0.65) | SLC2A4CYP1A2CYP3A4PKMALOX15 | |
| SCHEMBL10859843 | 0.88 | PDCD1 (0.53) | KMT2APDCD1CD274SMN1; SMN2 | |
| SCHEMBL9416529 | 0.86 | SLC2A4 (0.75) | SLC2A4CYP1A2CYP3A4PKMALOX15 | |
| SCHEMBL8584527 | 0.83 | SLC2A4 (0.57) | SLC2A4CYP1A2CYP3A4PKMALOX15 | |
| Phenol SCHEMBL28156093 | 0.82 | DRD4 (0.47) | CYP1A2CYP3A4PKMALOX15NFKB1 | |
| Resorcinol SCHEMBL10800197 | 0.81 | CYP3A4 (0.57) | CYP1A2CYP3A4PKMALOX15NFKB1 | |
| SCHEMBL17285992 | 0.80 | CYP1A2 (0.58) | SLC2A4CYP1A2CYP3A4PKMALOX15 | |
| SCHEMBL7023370 | 0.79 | ENPP2 (0.47) | CYP3A4NFKB1KMT2AENPP2PDCD1 | |
| SCHEMBL16619429 | 0.79 | CYP1A2 (0.61) | CYP1A2KDM4EPDCD1CD274SMN1; SMN2 | |
| SCHEMBL14294259 | 0.79 | PDCD1 (0.50) | CYP1A2LMNAPDCD1CD274SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455692-B2 | Process for resolution of 1-(3-hydroxyphenyl)-2-methylamino ethanol | Divi's Laboratories, Ltd. (IN) | 2013-06-04 | — | — | US | claimed |
| US-20120108848-A1 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL | DIVI'S LABORATORIES LIMITED (IN) | 2012-05-03 | — | — | US | claimed |
| EP-4543397-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2025-04-30 | — | — | EP | disclosed |
| EP-4543399-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2025-04-30 | — | — | EP | disclosed |
| EP-4543398-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2025-04-30 | — | — | EP | disclosed |
| EP-4543396-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023247616-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247618-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247615-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247610-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING SAID COMPOSITION | L'OREAL (FR) | 2023-12-28 | — | — | WO | disclosed |
| EP-2640713-A1 | ASCORBIC ACID DERIVATIVES AS OXIDATION DYE COMPONENTS | Merck Patent GmbH (DE) | 2013-09-25 | — | — | EP | disclosed |
| US-8455692-B2 | Process for resolution of 1-(3-hydroxyphenyl)-2-methylamino ethanol | Divi's Laboratories, Ltd. (IN) | 2013-06-04 | — | — | US | disclosed |
| US-8455692-B2 | Process for resolution of 1-(3-hydroxyphenyl)-2-methylamino ethanol | Divi's Laboratories, Ltd. (IN) | 2013-06-04 | — | — | US | disclosed |
| US-8455692-B2 | Process for resolution of 1-(3-hydroxyphenyl)-2-methylamino ethanol | Divi's Laboratories, Ltd. (IN) | 2013-06-04 | — | — | US | disclosed |
| WO-2012065685-A1 | ASCORBIC ACID DERIVATIVES AS OXIDATION DYE COMPONENTS | MERCK PATENT GMBH (DE) | 2012-05-24 | — | — | WO | disclosed |
| US-20120108848-A1 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL | DIVI'S LABORATORIES LIMITED (IN) | 2012-05-03 | — | — | US | disclosed |
| US-20120108848-A1 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL | DIVI'S LABORATORIES LIMITED (IN) | 2012-05-03 | — | — | US | disclosed |
| US-20120108848-A1 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL | DIVI'S LABORATORIES LIMITED (IN) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108848-A1 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL | ADH1A, CYP2E1, ADH1C | SLC2A4 4602/4885CYP1A2 13/4885CYP3A4 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.